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Medical thoracoscopyAbstract Background: The diagnostic approach to pleural disease remains an underappreciated
aspect of modern thoracic medicine, despite the fact that pleural disease affects approximately
300 subjects per 100,000 population per year worldwide. Tissue biopsies required for diagnosis
can be obtained by various methods; blind pleural biopsy, guided biopsy, medical thoracoscopic
or surgical pleural biopsy.
Aim of the work: To compare the diagnostic efﬁciency, reliability, complications and advantages
of transthoracic ultrasound guided (TUS) pleural biopsies with those of medical thoracoscopic
pleural biopsies in patients with pleural diseases.
Patients and methods: This study included 71 patients with pleural disease. All patients were sub-
jected to complete history taking, full clinical examination, CT chest, TUS examination with TUS
guided biopsies for legible cases and medical thoracoscopic biopsies for legible cases. The patients
included in the study were classiﬁed according to the procedure by which pleural biopsy was divided
into 3 groups: Group 1 (39 patients underwent medical thoracoscopic pleural biopsies alone),
Group 2 (10 patients underwent TUS pleural biopsies alone), Group 3 (22 patients underwent pleu-
ral biopsies by both techniques). The patients included in the study were classiﬁed according to the
pathology of the lesions into Group A (51 patients with malignant lesions) and Group B (included
20 patients with non-malignant lesions). The malignant patients included in the study were classiﬁed
according to the pathology of the lesions into Group A1 (24 patients with primary malignant
lesions) and Group A2 (27 patients cases with secondary malignant lesions).
Results: TUS guided pleural biopsies had a sensitivity of 77.78% and diagnostic accuracy of
81.25%; while medical thoracoscopic pleural biopsies had a sensitivity of 94% and a diagnostic
accuracy of 95.08%.
Conclusion: Both TUS guided pleural biopsy and medical thoracoscopic pleural biopsy are
available to diagnose different pleural lesions each of which has its advantages and disadvantages.
The proper selection of the patients for each modality will result in raising the diagnostic yield of
both modalities. TUS examination before medical thoracoscopy will allow proper selection ofdiseases,
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yield of medical thoracoscopy.
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The diagnostic approach to pleural disease remains an under-
appreciated aspect of modern thoracic medicine, despite the
fact that pleural disease affects approximately 300 subjects
per 100,000 population per year worldwide [1]. Yet, the most
efﬁcient and cost-effective approach to pleural diseases
remains uncertain and even controversial, particularly if acqui-
sition of pleural tissue is required.
Medical thoracoscopy allows for the direct inspection of the
pleura and biopsies taken under direct vision, has a diagnostic
yield superior to that of blind closed pleural biopsy and thora-
cocentesis. The diagnostic yield is in the order of 91–95% for
malignant disease and can be as high as 100% for pleural
TB [2]. Medical thoracoscopy remains an invasive procedure,
but complications are infrequently seen. Hemorrhage, sec-
ondary empyema and other major complications are only seen
in 2–3% of cases, and death is exceedingly rare (0.4%). In fact,
2010 British Thoracic Society (BTS) pleural disease guidelines
state that thoracoscopy is the investigation of choice in exuda-
tive pleural effusion where a diagnostic pleural aspiration is
inconclusive and malignancy is suspected [3].
Recent studies have proposed that image guided pleural
biopsies may signiﬁcantly increase the diagnostic yield over
blind pleural biopsies while decreasing the risk of complica-
tions. Transthoracic ultrasound (TUS) is an ideal aid to the
clinician, given its mobility, lack of irradiation and short exam-
ination time. TUS can locate the best pleural access point and
also detect thick ﬁbrous septation; it improves the accuracy of
pleural puncture sites by 26% [4]. TUS also allows access in
88% of patients after unsuccessful clinically guided thoraco-
centesis and reduces complications [5]. Moreover, the volume
of ﬂuid, the presence of septation, pleural thickening, nodules
and pleural based tumours can be accurately assessed [4].
These simple yet practical considerations need to be empha-
sized when comparisons are made with thoracoscopy.
This study aimed to compare the diagnostic efﬁciency, reli-
ability, complications and advantages of TUS pleural biopsies
with medical thoracoscopic pleural biopsies in patients with
pleural diseases.
Subjects
The present study included 71 patients who were selected from
the Chest Department inpatients, Kasr Alainy Hospital, in the
period from February 2013 to July 2014. The selected patients
had either exudative pleural effusion according to the light’s
criteria [6] pleural thickening, pleural nodules or pleural
masses that allow pleural biopsy to be performed. Patients
with transudative pleural effusion, bleeding disorders, exten-
sive adhesions with no sufﬁcient space to perform medical tho-
racoscopy or unﬁt for pleural biopsy procedures were excluded
from undergoing medical thoracoscopy. Patients with bleedingal., Ultrasound guided closed pleural bi
x.doi.org/10.1016/j.ejcdt.2016.08.007disorders or inaccessible pleural lesion for real time US guided
biopsy were excluded from undergoing closed pleural biopsy.
The included patients were divided into 3 subgroups
according to procedure by which pleural biopsy is obtained:
 Group I: included 39 patients who underwent medical tho-
racoscopic pleural biopsies alone (as lesions were inaccessi-
ble for TUS real time biopsies; e.g., behind rib).
 Group II: included 10 patients who underwent TUS pleural
biopsies alone (due to diffuse pleural thickening or exten-
sive thick adhesions with no space for medical
thoracoscopy).
 Group III: included 22 patients who underwent pleural
biopsies by both techniques.
The included patients were divided into 2 subgroups
according to the pathology of the lesions:
 Group A: included 51 patients with malignant lesions.
 Group B: included 20 patients with non- malignant lesions.
The malignant patients included in the study were divided
into 2 subgroups according to the pathology of the lesions:
 Group A1: included 24 patients with primary malignant
lesions.
 Group A2: included 27 patients with secondary malignant
lesions.
Methods
All included patients were subjected to:
- Written informed consent.
- Full history taking.
- Detailed clinical examination.
- Bleeding proﬁle.
- CT scan of the chest which was used to detect the following:
(a) The presence of pleural nodules (lesions <3 cm in lar-
gest diameter) or pleural masses (lesions >3 cm in lar-
gest diameter).
(b) Pleural ﬁbrosis and pleural effusion (free or loculated).
(c) The character of the collapsed lung either bulky collapse
(lung that didn’t collapse totally under the effusion with
no aeration and preserved some volume) or healthy col-
lapse (lung that collapsed totally under the effusion).
- Biochemical, pathological and microbiological evaluation
of the pleural aspirates for cases with pleural effusion.
- Transthoracic ultrasonographic study with ultrasound
guided pleural biopsy in legible cases: (using Hitachi
7000). All cases were examined with curvilinear transducer
(3.5 MHz) and linear array transducer (7.5 MHz).opsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases,
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probe. Detection of pleural effusion, pleural thickness, pleural
nodules (lesions <3 cm in largest diameter) or pleural masses
(lesions >3 cm in largest diameter). Detection of the character
of the collapsed lung either bulky collapse (lung that didn’t col-
lapsed totally under the effusion with no aeration and pre-
served some volume) or healthy collapse (lung that collapse
totally under the effusion).
Also the size of the effusion was documented as follows:
Mild (if the space was greater than the costophrenic angle
but still within the range of the area covered with a 3.5 MHz
curvilinear probe), moderate (if the space was greater than
one probe range but within a two probe range and Massive
(if the space was larger than a two-probe range).
For US guided biopsies, the biopsy site was identiﬁed and
all biopsies were performed using semi-automatic Tru cut nee-
dle under direct TUS guidance, while in cases who underwent
Abrams pleural biopsy the best site for biopsy was marked by
TUS and biopsy was taken blindly. At least three Tru-cut nee-
dle biopsies were taken using a 14 gauge cutting needle then all
the biopsies were sent for histopathological examination [7].
- Medical thoracoscopic pleural biopsy was done in legible
cases using KARL-STORZ rigid thoracoscopy with a cold
light source. The single-entry technique for medical thora-
coscopy was used in all cases. The puncture site is usually
in the mid- axillary zone between the 4th and 6th intercostal
spaces. Choice of the point of entry varied depending on
the site of dullness, guided by CT chest [8] and TUS exam-
ination pre-medical thoracoscopy to detect the best site of
entry.
Good inspection of the lung surface and pleural cavity was
done to detect the presence of pleural nodules (lesions <3 cm
in largest diameter) or pleural masses (lesions >3 cm in largest
diameter), compared to the length of open forceps’ jaw which
was found to be 1 cm. Also the character of the collapsed
Lung, after aspiration of pleural effusion, by gentle pushing
of closed forceps was assessed and classiﬁed into: (i) bulky lung
with doughy sensation on pushing by closed forceps; (ii)
healthy collapsed lung with spongy sensation.
Multiple biopsies were taken under direct vision from sus-
picious sites on parietal (especially posterior costodiaphrag-
matic recess) or diaphragmatic pleurae. Sometimes lung
(recommended sonographically), biopsies were obtained using
electrocautery forceps. All thoracoscopic pleural and lung
biopsies were sent for histopathological examination.
Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), median and range, or frequencies (number
of cases) and percentages when appropriate. Comparison of
numerical variables between the study groups was done using
Student t test for independent samples by comparing 2 groups
when normally distributed and Mann–Whitney U test for inde-
pendent samples when not normally distributed. Comparison
of numerical variables between more than two groups in the
present study was done using Kruskal–Wallis test. Within
group comparison of numerical variables was done using
paired t test by comparing 2 groups when normally distributedPlease cite this article in press as: K. Sobhy et al., Ultrasound guided closed pleural bio
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when not normally distributed. For comparing categorical
data, Chi square (v2) test was performed. Exact test was used
instead when the expected frequency is less than 5. Compar-
ison and agreement between the different diagnostic modalities
were done using McNemar and kappa tests. Accuracy was rep-
resented using the terms sensitivity, speciﬁcity, +ve predictive
value, ve predictive value, and overall accuracy. p values less
than 0.05 were considered statistically signiﬁcant. All statistical
calculations were done using computer program SPSS (Statis-
tical Package for the Social Science; SPSS Inc., Chicago, IL,
USA) release 15 for Microsoft Windows (2006).
Results
The present study included 71 patients who fulﬁlled the selec-
tion criteria and formed the study population. The study
patients were divided into 3 groups; Group I: included 39 cases
who underwent medical thoracoscopic pleural biopsy alone,
(they were 11 males and 28 females with a mean age of
53.69), Group II: included 10 cases who underwent TUS
guided pleural biopsies (they were 8 males and 2 females with
a mean age of 61.07), Group III: included 22 cases who under-
went biopsies by both techniques (they were 11 males and 11
females with a mean age of 55.45).
The patients included in the study were also classiﬁed
according to the ﬁnal histopathological results, into two
groups; Group A: included 51 cases with malignant lesions
(they were 24 males and 27 females with mean age of 57.2)
and Group B: included 20 cases with non-malignant lesions
(they were 6 males and 14 females with a mean age of
49.479). The malignant patients included in the study (Group
A) were further classiﬁed into Group A1: included 24 cases
with primary malignant lesions (they were 13 males and 11
females with a mean age of 58.3) and Group A2: included 27
cases with secondary malignant lesions (they were 11 males
and 16 females with an average age of 55.8).
Regarding site of lesions, CT chest revealed that 54.9% of
cases had right sided lesions, 39.5% of cases had left sided
lesions and 5.6% had bilateral lesions and TUS data revealed
that 56.3% of cases had right sided lesions, 40.9% had left
sided lesions and 2.8% of cases had bilateral lesions.
Regarding the comparison between medical thoracoscopy
and either CT chest or TUS in the ability of detection of pleu-
ral masses there was no statistically signiﬁcant difference
(Table 1), also there was no statistically signiﬁcant difference
comparing them together (Table 2).
Comparing the ability to detect pleural nodules by CT chest
or TUS versus medical thoracoscopy, this study revealed that
there was no statistically signiﬁcant difference between TUS
and medical thoracoscopy (p= 0.570) (Table 3), while medical
thoracoscopy was superior over CT chest in detection of pleu-
ral nodules with statistically signiﬁcant difference (p= 0.000)
(Table 3), while comparing the ability to detect pleural nodules
by medical thoracoscopy, CT chest and TUS, this study
revealed that there was statistically signiﬁcant difference
(p= 0.001) (Table 2).
Regarding the ability to detect pleural nodules by TUS
(Table 4), (Fig. 1) there was statistically signiﬁcant difference
(p= 0.025) between malignant (group A) and non-malignant
groups (group B) but there was no signiﬁcant differencepsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases,
Table 1 Comparison between either CT chest or TUS and medical thoracoscopy in detection of pleural masses among study patients
who underwent medical thoracoscopy.
Thoracoscope masses p value
No Yes Total
CT Masses No 54 (88.5%) 4 (6.6%) 58 (95.1%) 0.299
Yes 1 (1.6%) 2 (3.3%) 3 (4.9%)
Total 55 (90.1%) 6 (9.9%) 61 (100%)
TUS Masses No 54 (88.5%) 2 (3.3%) 56 (91.8%) 0.752
Yes 1 (1.6%) 4 (6.6%) 5 (8.2%)
Total 55 (90.1%) 6 (9.9%) 61 (100%)
4 K. Sobhy et al.(p= 1.00) between primary (group A1) and secondary malig-
nant cases (group A2). Regarding the ability of medical thora-
coscopy in detection of pleural nodules (Table 4), (Fig. 1) there
was statistically signiﬁcant difference (p= 0.009) between
group A and group B but no signiﬁcant difference
(p= 0.405) between group A1 and group A2.
Also TUS detected chest wall invasion among malignant
cases and conﬁrmed its absence in non-malignant cases, with
statistically signiﬁcant value (p-value = 0.015) (Table 5), while
CT chest couldn’t detect any case with chest wall invasion.
Comparing the ability to detect the character of the col-
lapsed lung (bulky or healthy collapse) by CT chest or TUS
versus medical thoracoscopy, this study revealed that TUS
was the best modality to detect bulky lung (Table 6), also com-
paring the ability to detect character of the collapsed lung by
medical thoracoscopy, CT chest and TUS there was no statis-
tically signiﬁcant difference (p= 0.065) (Table 7).
This study revealed that TUS was the best modality to
detect lung mass in the secondary malignant group with statis-
tically signiﬁcant difference (p= 0.004) (Table 8), (Fig. 1).
Comparing the ability to detect the pattern of pleural effu-
sion (free or loculated) by CT chest or TUS versus medical
thoracoscopy, this study revealed that all techniques were close
to each other, with no signiﬁcant difference between all of
them (Tables 9 and 10).
Regarding the diagnostic yield of used modalities for diag-
nosis of pleural diseases in the present study it was found that
the diagnostic yield of TUS was close to that of medical thora-
coscopy but the difference between them didn’t reach statisti-
cal signiﬁcance (p= 0.079) (Table 11).
Regarding the complications of both TUS guided biopsy
and medical thoracoscopic biopsy, TUS guided biopsies
showed no complications compared to 7 (11.5%) patientsTable 2 Comparison between medical thoracoscopy, CT chest and T
patients who underwent medical thoracoscopy.
Medical thoracoscopy
Pleural masses Yes 6 (9.9%)
No 55 (90.1%)
Total 61 (100%)
Pleural nodules Yes 55 (90.2%)
No 6 (9.8%)
Total 61 (100%)
* p< 0.05.
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biopsies including 4 cases with surgical emphysema and 3 cases
with wound infection and empyema.
Discussion
The diagnostic approach to pleural diseases remains an under-
appreciated aspect of modern thoracic medicine, despite the
fact that pleural diseases affect approximately 300 subjects
per 100,000 population per year worldwide [1].
Medical thoracoscopy allows for the direct inspection of the
pleura and biopsies taken under direct vision, has a diagnostic
yield superior to that of blind closed pleural biopsy and
thoracocentesis. The diagnostic yield is in the order of
91–95% for malignant disease and can be as high as 100%
for pleural TB [2].
In fact, 2010 British Thoracic Society (BTS) pleural disease
guidelines state that thoracoscopy is the investigation of choice
in exudative pleural effusion where a diagnostic pleural aspira-
tion is inconclusive and malignancy is suspected [3].
Recent studies have proposed that image guided pleural
biopsies using TUS may signiﬁcantly increase the diagnostic
yield over blind pleural biopsies while decreasing the risk of
complications.
The aim of the current study was to compare the diagnostic
efﬁciency, reliability, complications and advantages of TUS
biopsies with that of medical thoracoscopic biopsies in patients
with pleural diseases.
Regarding site of lesions according to data of CT chest
54.9% of cases had right sided lesions, 39.5% of cases had left
sided lesions and 5.6% had bilateral lesions. TUS data
revealed that 56.3% of cases had right sided lesions, 40.9%
had left sided lesions and 2.8% of cases had bilateral lesions.US in detection of pleural masses & pleural nodules among study
CT chest TUS p value
3 (4.9%) 5 (8.25%) 0.581
58 (95.1%) 56 (91.8%)
61 (100%) 61 (100%)
7 (11.5%) 53 (86.9%) 0.001*
54 (88.5%) 8 (13.1%)
61 (100%) 61 (100%)
opsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases,
Table 3 Comparison between either CT chest or TUS and medical thoracoscopy in detection of pleural nodules among patients who
underwent medical thoracoscopy.
Thoracoscope nodule p value
No Yes Total
CT nodule No 6 (9.8%) 48 (78.7%) 54 (88.5%) 0.000*
Yes 0 (0%) 7 (11.5%) 7 (11.5%)
Total 6 (9.8%) 55 (90.2%) 61 (100%)
TUS nodule No 5 (8.1%) 3 (5%) 8 (13.1%) 0.570
Yes 1 (1.7%) 52 (85.2%) 53 (86.9%)
Total 6 (9.8%) 55 (90.2%) 61 (100%)
* p< 0.05.
Table 4 Study the ability of TUS & medical thoracoscopy to detect pleural nodules among the study patients.
Malignant Non malignant Grand total p-Value
Primary Secondary Total p-Value
TUS Yes 22 (31%) 25 (35.2%) 47 (66.2%) 1.000 14 (19.7%) 61 (85.9%) 0.025*
No 2 (2.8%) 2 (2.8%) 4 (5.6%) 6 (8.5%) 10 (14.1%)
Total 24 (33.8%) 27 (38%) 51 (71.8%) 20 (28.2%) 71 (100%)
Medical thoracoscopy Yes 16 (26.2%) 25 (41%) 41 (67.2%) 0.405 14 (23%) 55 (90.2) 0.009*
No 1 (1.6%) 0 (0%) 1 (1.6%) 5 (8.2%) 6 (9.8%)
Total 17 (27.8%) 25 (41%) 42 (68.8%) 19 (31.2%) 61 (100%)
* p< 0.05.
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that 70% of cases had right sided lesions and 30% had left side
lesions.
Regarding the comparison between medical thoracoscopy
and either CT chest or TUS in the ability of detection of pleu-
ral masses there was no statistically signiﬁcant difference
(Table 1), also there was no statistically signiﬁcant difference
comparing them together (Table 2). This study showed that
either medical thoracoscopy or TUS could be reliably used
in detection of pleural masses. TUS still has some advantages
over CT in detecting and diagnosing pleural masses: (1) prac-
tically, some patients with pleural masses and pleural effusions
often had complaints of dyspnea and chronic cough; therefore,
it was difﬁcult or impossible for these patients to lie in bed for
a thoracic CT examination and CT-guided needle biopsies (2)
detecting the pleural masses in real-time and making needle
biopsies simultaneously [10].
Comparing the ability to detect pleural nodules by CT chest
or TUS versus medical thoracoscope, this study revealed that
there was no statistically signiﬁcant difference between TUS
and medical thoracoscopy (p= 0.570) (Table 3), while medical
thoracoscopy was superior over CT chest in detection of pleu-
ral nodules with statistically signiﬁcant difference (p= 0.000)
(Table 3), Also comparing the ability to detect pleural nodules
by medical thoracoscopy, CT chest and TUS, this study
revealed that there was statistically signiﬁcant difference
(p= 0.001) (Table 2), so either medical thoracoscopy or
TUS could be reliably used in detection of pleural nodules.
Regarding the ability to detect pleural nodules by TUS
(Table 4), there was statistically signiﬁcant differencePlease cite this article in press as: K. Sobhy et al., Ultrasound guided closed pleural bio
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groups (group B) but there was no signiﬁcant difference
(p= 1.00) between primary (group A1) and secondary malig-
nant cases (group A2). Regarding the ability of medical thora-
coscopy in detection of pleural nodules (Table 4), there was
statistically signiﬁcant difference (p= 0.009) between group
A and group B but no signiﬁcant difference (p= 0.405)
between group A1 and group A2, as direct visualization of
the pleural surface during medical thoracoscopy helps to sus-
pect a diagnosis and permits targeted biopsy from the abnor-
mal pleural regions under direct vision.
This study showed that pleural nodules detected by Medical
Thoracoscopy in 67.2% of cases and by TUS in 66.2% of cases
were malignant as conﬁrmed histopathologically (Table 4).
These results coincide with Enas et al. [9] who stated that sono-
graphic appearances of pleural nodules were mostly malignant,
as conﬁrmed histologically.
Regarding the ability of TUS to detect chest wall invasion
(Table 5), there was statistically signiﬁcant difference
(p= 0.015) between malignant and non-malignant groups
and there was no signiﬁcant difference (p= 0.511) between
primary malignant and secondary malignant cases, while CT
chest couldn’t detect any case of chest wall invasion.
Comparing the ability to detect the character of the col-
lapsed lung (bulky or healthy collapse) by CT chest or TUS
versus medical thoracoscopy, this study revealed that TUS
was the best modality to detect bulky lung (Tables 6 and 7).
As TUS is a dynamic technique -and with the presence of
adequate window – it could visualize beyond the visceral
pleura and give an idea about the nature of the collapsed lungpsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases,
Figure 1 Female patient 30 years old, presented by gradual progressive dyspnea of 6 month duration. (a) CXR-PA showing moderate
right sided pleural effusion with right paratracheal homogenous opacity, (b) CT chest mediastinal window showing right sided pleural
effusion and bulky collapse of right upper lobe, (c)TUS showing complex non septated pleural effusion with nodule over diaphragmatic
pleura, (d)TUS showing bulky right upper lobe with ﬂuid bronchogram, (e) Medical Thoracoscopic picture showing nodule over costal
pleura, (f) Medical Thoracoscopic picture showing biopsy from pleural nodule over costal pleura, (g) Medical Thoracoscopic picture
showing lung biopsy from right upper lobe, (h) Medical Thoracoscopic picture showing cautery site post lung biopsy, (i) histopathological
picture showing metastatic adenocarcinoma (H&E, 200).
Table 5 Chest wall invasion as detected by TUS among the study patients.
Malignant Non malignant Total p-Value
Primary Secondary Total p-value
Yes 7 (9.9%) 5 (7%) 12 (16.9%) 0.511 0 (0%) 12 (16.9%) 0.015*
No 17 (23.9%) 22 (31%) 39 (54.9%) 20 (28.2%) 59 (83.1%)
Total 24 (33.8%) 27 (38%) 51 (71.8%) 20 (28.2%) 71 (100%)
* p< 0.05.
6 K. Sobhy et al.either compression collapse under effusion or obstructive
collapse due to central obstruction causing distal collapse (this
could be detected by the presence of ﬂuid bronchogram), Also
medical thoracoscopy is a dynamic technique but it lacks the
ability to detect beyond visceral pleura and lung surface.
This study revealed that TUS was the best modality to
detect lung mass in secondary malignant group with statisti-
cally signiﬁcant difference (p= 0.004) (Table 8), (Fig. 1).
The present study showed that TUS is superior over
medical thoracoscopy in detection of lung masses and bulky
lung, as TUS had the ability to visualize beyond visceral pleura
– if there is available interface- and could detect vascularity of
the lesion using Doppler wave and give an idea about itsPlease cite this article in press as: K. Sobhy et al., Ultrasound guided closed pleural bi
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.08.007nature (benign, malignant) while medical thoracoscopy could
only detect the visceral pleura and outer surface of the lung
with provisional idea about the character of lung.
This advantage of TUS allowed us to take TUS guided
biopsies from mass lesions in the lung in 3 cases and all these
biopsies were diagnostic and guided us to take thoracoscopic
lung biopsy in another 4 cases and all these biopsies were
diagnostic.
There were no comparative studies assessing lung character
by CT chest, TUS and medical thoracoscopy relative to each
other.
Comparing the ability to detect pattern of pleural
effusion (free or loculated) by CT chest, TUS and medicalopsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases,
Table 6 Comparison between either CT chest or TUS and medical thoracoscopy in detection character of collapsed lung among
patients who underwent medical thoracoscopy.
Thoracoscope character of collapsed lung p value
Bulky Healthy Total
CT character of collapsed lung Bulky 5 (8.2%) 0 (0%) 5 (8.2%) 0.379
Healthy 3 (4.9%) 53 (86.9%) 56 (91.8%)
Total 8 (13.1%) 53 (86.9%) 61 (100%)
TUS character of collapsed lung Bulky 7 (11.5%) 7 (11.5%) 14 (23%) 0.158
Healthy 1 (1.6%) 46 (75.4%) 47 (77%)
Total 8 (13.1%) 53 (86.9%) 61 (100%)
Table 7 Comparison between medical thoracoscopy, CT chest and TUS in detection of character of collapsed lung among study
patients who underwent medical thoracoscopy.
Medical thoracoscopy CT chest TUS p value
Character of collapsed lung Bulky 8 (13.1%) 5 (8.2%) 14 (23%) 0.065
Healthy 53 (86.9%) 56 (91.8%) 47 (77%)
Total 61 (100%) 61 (100%) 61 (100%)
Table 8 The ability of CT & TUS to detect lung mass in malignant subgroups.
Primary malignant Secondary malignant Total p-Value
CT Yes 0 (0%) 3 (5.8%) 3 (5.8%) 0.0923
No 24 (47.1%) 24 (47.1%) 48 (94.2%)
Total 24 (47.1%) 27 (52.9%) 51 (100%)
TUS Yes 1 (2%) 13 (25.5%) 14 (27.5%) 0.0004*
No 23 (45%) 14 (27.5%) 37 (72.5%)
Total 24 (47%) 27 (53%) 51 (100%)
* p< 0.05.
Table 9 Comparison between either CT chest or TUS and medical thoracoscopy in detecting pattern of pleural effusion in patients
who underwent medical thoracoscopy.
Thoracoscope pattern p value
Free Loculated Total
CT pattern Free 36 (59%) 2 (3.3%) 38 (62.3%) 0.076
Loculated 11 (18%) 12 (19.7%) 23 (37.7%)
Total 47 (77%) 14 (23%) 61 (100%)
TUS pattern Free 42 (68.9%) 3 (4.9%) 45 (73.8%) 0.619
Loculated 5 (8.2%) 11 (18%) 16 (26.2%)
Total 47 (77.1%) 14 (22.9%) 61 (100%)
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Table 12 The sensitivity and diagnostic accuracy of TUS
guided biopsies and medical thoracoscopic biopsies.
TUS biopsies
(n= 32)
Medical thoracoscopic
biopsies (n= 61)
True positive 21 (65.6%) 47 (77.1%)
False negative 6 (18.8%) 3 (4.9%)
True negative
(pleural ﬁbrosis)
5 (15.6%) 11 (18%)
Sensitivity of TUS guided biopsies (%) = 77.78%.
Diagnostic accuracy of TUS guided biopsies (%) = 81.25%.
Sensitivity of Medical Thoracoscopic biopsies (%) = 94%.
Diagnostic accuracy of Medical Thoracoscopic biopsies (%)
= 95.08%.
8 K. Sobhy et al.thoracoscopy, this study revealed that all techniques were close
to each other, with no signiﬁcant difference between all of
them (Tables 9 and 10).
Adel et al. [11] stated that in TUS diagnosed 83.3% of free
pleural effusion lesions, 60%of encysted pleural effusion lesions
and diagnosed all empyema lesions, however it was less sensitive
in detecting pleural thickening and pleural nodules or masses.
Also Sikora et al. [12] stated that transthoracic US serves as
a more accurate imaging tool than chest radiography for the
diagnosis of pleural effusions and allows discrimination of
pleural effusions from other lung pathology that may appear
similar on a chest radiograph. Furthermore, US can allow
diagnosis of complicated pleural effusions, such as empyemas
that may be associated with a higher risk of drainage.
Regarding the diagnostic yield of used modalities for diag-
nosis of pleural diseases in the present study it was found that
the diagnostic yield of TUS was close to that of medical thora-
coscopy but the difference between them didn’t reach statisti-
cal signiﬁcance (p= 0.079) (Table 11).
Regarding the complications of both procedures, TUS
guided biopsies showed no complications compared to 7
(11.5%) patients who developed complications following med-
ical thoracoscopic biopsies including 4 cases of surgical
emphysema and 3 cases of wound infection and empyema.
The reported incidence of complications following medical
thoracoscopic pleural biopsy was about 3% as stated by Han-
sen et al. [13] and 40.3% as stated by Metintas et al. [14].
According to a retrospective study by Blanc et al. [15]
reported that out of 168 thoracoscopic procedures, 0.6%
developed major complications that included death, severe
sepsis, pulmonary embolism, hypercapnic coma while
empyema was detected in (3.6%) of cases. On the other hand
minor complications included residual pneumothorax (8.3%),
subcutaneous emphysema (5.3%), fever (3.6%).
Mootha et al. [16] reported that out of 35 thoracoscopic
procedures, 2 cases (5.2%) developed empyema with no other
complications.
Also Prabhu and Narasimhan [17] found that out of 68
patients who underwent medical thoracoscopy, there were no
major complications, only 4 patients had minor complicationsTable 10 Comparison between medical thoracoscopy, CT chest an
underwent medical thoracoscopy.
Medical thorac
Pattern of pleural eﬀusion Free 47 (77%)
Loculated 14 (23%)
Total 61 (100%)
Table 11 Comparison between diagnostic yield of TUS and medic
Thoracoscope results
No
TUS results No 0 (0%)
Yes 1 (4.5%)
Total 1 (4.5%)
Please cite this article in press as: K. Sobhy et al., Ultrasound guided closed pleural bi
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.08.007like subcutaneous emphysema (3 patients) and prolonged air
leak (1 patient).
Abumossalam et al. [18] stated that complications reported
in their study were few and of low risk. Five patients (7.25%)
had thoracoscopic-related complications during this study.
Two of them had empyema (2.89%); one had a residual pneu-
mothorax (1.45%), one had subcutaneous emphysema
(1.45%) and one had tumor implantation at the site of medical
thoracoscopy tract (1.45%). These complications were prop-
erly managed. No bleeding or mortality was reported in their
study and mortality rate was 0%.
The reported incidence of complications following closed
pleural biopsy was about 10.9% as stated by Mungal [19]
and 22.5% as stated by Metintas et al. [14] while the reported
incidence of complications following image guided Tru-cut
pleural biopsy was about 3% (Benamore et al. [7]).
Enas et al. [9] stated 10% of patients underwent TUS biop-
sies developed complications and 10% of patients underwent
medical thoracoscope developed complications in the form of
empyema and wound infections.
TUS guided biopsies had sensitivity of 77.78% and
diagnostic accuracy of 81.25% (Table 12); while medicald TUS in detecting pattern of pleural effusion in patients who
oscopy CT chest TUS p value
38 (62.3%) 45 (73.8%) 0.169
23 (37.7%) 16 (26.2%)
61 (100%) 61 (100%)
al thoracoscopy results in 22 cases underwent both procedures.
p value
Yes Total
5 (22.8%) 5 (22.8%) 0.079
16 (72.7%) 17 (77.2%)
21 (95.5%) 22 (100%)
opsy versus medical thoracoscopic pleural biopsy in diagnosis of pleural diseases,
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tic accuracy of 95.08% (Table 12).
The diagnostic yield of thoracoscopy is high; it is reported
to be above 90% in the majority of studies and sensitivity
between 90 and 95% Boutin et al. [20] diagnostic yield of med-
ical thoracoscopy was 97%, Blanc et al. [15] diagnostic yield of
medical thoracoscopy was 93.3%.
Chang et al. [21] previously found the diagnostic yield of
US guided Tru-cut pleural biopsy to be as high as 87% for
all pleural pathologies.
Diacon et al. [22] reported an 86% sensitivity and a 100%
speciﬁcity with transthoracic ultrasonography-guided biopsy
when they used a 14-gauge cutting needle for pleura-based
lesions 20 mm or greater in diameter.
Koegelenberg et al. [23] the respective yield for both
US-assisted Abrams or Tru-cut needle types for pleural malig-
nancies was comparable and relatively high being diagnostic in
approximately 83.3% of cases.
Enas et al. [9] stated sensitivity of medical thoracoscopy
was 100% and a sensitivity of TUS guided biopsies were 90%.
In the present study 7 cases out of 32 cases of US guided
biopsy underwent Abrams guided biopsies however none of
them were diagnosed by this modality, their histopathological
examination showed minimal representative pleural tissue and
skeletal muscle, this may be related to the technique of the pro-
cedure as site of biopsy is directed by US while at time of
biopsy taking it’s blind and may hinge on any tissue through
its path so that it may not submit adequate pleural tissue suf-
ﬁcient for diagnosis.
On the other hand, Koegelenberg et al. [23] in a prospective
randomized study found that US-assisted Abrams needle
biopsy specimens were more likely to contain pleural tissue
than specimens obtained by means of US-assisted Tru-cut
biopsies (91.0% versus 78.7%, p= 0.015). Furthermore,
Abrams needle biopsies had a signiﬁcantly superior yield for
pleural TB compared to Tru-cut needle biopsies (81.8% versus
65.2%, p= 0.022), but not compared with previously reported
ﬁgures for blind Abrams needle biopsies.
Ahmed et al. [24] stated that, out of 20 patients who under-
went image-assisted Abram needle pleural biopsy, 15 patients
were diagnosed; 7 patients diagnosed with benign disease
and 8 patients diagnosed with malignant disease, with an over-
all diagnostic sensitivity of 75%. Also, out of 20 patients who
underwent medical thoracoscopy, 17 patients were diagnosed;
8 patients diagnosed with a benign disease and 9 patients diag-
nosed with malignant disease, with an overall diagnostic sensi-
tivity of 85%. The increased sensitivity of the image-assisted
Abram needle biopsy technique used in this study had been
attributed to its use in a pleural thickening of 1 cm or more,
and by using a tangential approach, to achieve adequate diag-
nostic samples, in patients with thin pleural thickening less
than 1 cm.
Conclusion and recommendations: TUS examination
before medical thoracoscopy will allow proper selection of
patients, reduce incidence of complications, guide for best site
of entry and raise diagnostic yield of medical thoracoscopy.
Both TUS guided pleural biopsy and medical thoracoscopic
pleural biopsy are available to do biopsies of different pleural
lesions and each of which had its advantages and disadvan-
tages. The proper selection of the patients for each modality
will result in raising the diagnostic yield of both modalities.Please cite this article in press as: K. Sobhy et al., Ultrasound guided closed pleural bio
Egypt. J. Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.08.007Use of TUS in detection of the best site for entrance of
medial thoracoscope in cases of absence of pleural effusion
(selection of site of best lung sliding to avoid visceral and pari-
etal pleural adhesions).
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